• All
  • Executive Search
  • Finance
  • M&A
  • Views

NEW YORK--(BUSINESS WIRE)--OrbiMed, a leading life sciences investment firm, announced $3.5 billion in commitments for its latest private investment funds, including $1.5 billion for OrbiMed Private Investments VIII, $800 million...

Simplify Cervical Artificial Disc provides NuVasive most clinically effective technology in the cervical total disc replacement (cTDR) procedure segment Expands growth opportunities and further differentiates Company’s comprehensive portfolio across ACDF, PCF,...